Here are updates on two of our buys

Article Excerpt

Long-time readers know that we aim to keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to bolster investor gains. Here are two buys that stand out this month: THERMO FISHER SCIENTIFIC INC., $528.87, is a buy. The company (New York symbol TMO; TSINetwork Rating: Average) (thermofisher.com; Shares o/s: 385.9 million; Market cap: $206.3 billion; Dividend yield: 0.3%) is a leading maker of scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents. In the quarter ended July 1, 2023, Thermo Fisher’s revenue fell 2.6%, to $10.69 billion from $10.97 billion a year earlier. The decline was mostly due to lower revenue from COVID-related sales of testing equipment as the pandemic eased. Without that, revenue rose by 2%. Excluding one-time items, per-share earnings fell 6.5%, to $5.15 from $5.51. Earnings fell along with sales. Overall, Thermo Fisher has relied on acquisitions for growth; it also has a high p/e and low yield. That combination leaves its…